In the BioHarmony Drug Report Database
Fosdenopterin
Nulibry (fosdenopterin) is a small molecule pharmaceutical. Fosdenopterin was first approved as Nulibry on 2021-02-26. Nulibry’s patent is valid until 2025-01-31 (FDA).
Trade Name
|
Nulibry |
|---|---|
Common Name
|
fosdenopterin |
ChEMBL ID
|
CHEMBL2338675 |
Indication
|
|
Drug Class
|
Phosphoro-derivatives |
Image (chem structure or protein)